Name | Erenumab |
---|
Description | Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |